Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Psychiatry AND Tardive dyskinesia)
1,887 results
  • Tardive dyskinesia: 21st century may bring new treatments to a forgotten disorder. [Journal Article]
  • ACAnn Clin Psychiatry 2017 Feb 01; 29(1):e9-e20
  • Rakesh G, Muzyk A, … Masand P
  • CONCLUSIONS: There continues to be a substantial prevalence rate for the condition with the use of first-generation and second-generation antipsychotics. Because of the potential irreversible nature, legal implication, and high prevalence of TD, we advocate for more research on new treatments for the disorder.
  • Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study. [Journal Article]
  • JCJ Clin Psychopharmacol 2017; 37(2):125-130
  • Glick ID, Davis JM, … Nuthi M
  • CONCLUSIONS: In this naturalistic study, patients who adhered to antipsychotic medication had better long-term global outcomes than those who had poor adherence. Study limitations include the potential for residual confounding. This sample provides data consistent with the recommendation, in the absence of clinically important unwanted drug effects like tardive dyskinesia or large weight gain, for continuous, long-term antipsychotic treatment for chronic schizophrenia.
New Search Next